1,4-Diaminocyclohexane → HCID 178511658, compound
Reaction equation
[CH2:1]1[CH:6]([NH2:7])[CH2:5][CH2:4][CH:3]([NH2:8])[CH2:2]1.C1(S([N:18]2[C:22]3=[N:23][CH:24]=[CH:25][CH:26]=[C:21]3[C:20]([C:27]3[CH:32]=[CH:31][N:30]=[C:29](Cl)[N:28]=3)=[CH:19]2)(=O)=O)C=CC=CC=1>>[NH:18]1[C:22]2=[N:23][CH:24]=[CH:25][CH:26]=[C:21]2[C:20]([C:27]2[CH:32]=[CH:31][N:30]=[C:29]([NH:7][C@H:6]3[CH2:5][CH2:4][C@H:3]([NH2:8])[CH2:2][CH2:1]3)[N:28]=2)=[CH:19]1Participants
3
Procedure
Using the procedure of example 1, trans-1,4-cyclohexyldiamine (277 mg) was reacted with compound 1f (300 mg) to provide compound 42 (86 mg, 34%). 1H NMR (400 MHz, CD3OD) δ 8.90 (d, J=8.0 Hz, 1H), 8.25 (d, J=5.6 Hz, 1H), 8.17 (s, 1H), 8.12 (d, J=8.0 Hz, 1H), 7.22 (m, 1H), 6.95 (d, J=5.6 Hz, 1H), 3.85 (m, 1H), 2.78 (m, 1H), 2.18 (m, 2H), 2.20 (m, 2H), 1.40 (m, 4H). MS (ESI) m/z: 309 (M+H)+.
Sources & evidence
- ORD record
- ord-48be8ef451d14a60b44ef917abf9e6bb
- Source dataset
- uspto-grants-2010_12
- Patent number
- US07855205B2
Reaction notes
Loading…